These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32380416)

  • 1. Poly(Beta-Amino Ester) Nanoparticles Enable Nonviral Delivery of CRISPR-Cas9 Plasmids for Gene Knockout and Gene Deletion.
    Rui Y; Varanasi M; Mendes S; Yamagata HM; Wilson DR; Green JJ
    Mol Ther Nucleic Acids; 2020 Jun; 20():661-672. PubMed ID: 32380416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic investigation of CRISPR-Cas9 configurations for flexible and efficient genome editing in Corynebacterium glutamicum NRRL-B11474.
    Cameron Coates R; Blaskowski S; Szyjka S; van Rossum HM; Vallandingham J; Patel K; Serber Z; Dean J
    J Ind Microbiol Biotechnol; 2019 Feb; 46(2):187-201. PubMed ID: 30484125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9.
    Hosseini ES; Nikkhah M; Hosseinkhani S
    Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and Evaluation of pH-Sensitive Multifunctional Lipids for Efficient Delivery of CRISPR/Cas9 in Gene Editing.
    Sun D; Sun Z; Jiang H; Vaidya AM; Xin R; Ayat NR; Schilb AL; Qiao PL; Han Z; Naderi A; Lu ZR
    Bioconjug Chem; 2019 Mar; 30(3):667-678. PubMed ID: 30582790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
    Wang HX; Song Z; Lao YH; Xu X; Gong J; Cheng D; Chakraborty S; Park JS; Li M; Huang D; Yin L; Cheng J; Leong KW
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4903-4908. PubMed ID: 29686087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducible Branched Ester-Amine Quadpolymers (rBEAQs) Codelivering Plasmid DNA and RNA Oligonucleotides Enable CRISPR/Cas9 Genome Editing.
    Rui Y; Wilson DR; Sanders K; Green JJ
    ACS Appl Mater Interfaces; 2019 Mar; 11(11):10472-10480. PubMed ID: 30794383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapy.
    Niu G; Jin Z; Zhang C; He D; Gao X; Zou C; Zhang W; Ding J; Das BC; Severinov K; Hitzeroth II; Debata PR; Ma X; Tian X; Gao Q; Wu J; You Z; Tian R; Cui Z; Fan W; Xie W; Huang Z; Cao C; Xu W; Xie H; Xu H; Tang X; Wang Y; Yu Z; Han H; Tan S; Chen S; Hu Z
    EBioMedicine; 2020 Aug; 58():102897. PubMed ID: 32711250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes.
    Sousa DA; Gaspar R; Ferreira CJO; Baltazar F; Rodrigues LR; Silva BFB
    Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Delivery of CRISPR/Cas9 System Using Magnetic Nanoparticles into Porcine Fibroblast.
    Hryhorowicz M; Grześkowiak B; Mazurkiewicz N; Śledziński P; Lipiński D; Słomski R
    Mol Biotechnol; 2019 Mar; 61(3):173-180. PubMed ID: 30560399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells.
    Moradi P; Hasanzadeh A; Radmanesh F; Rajai Daryasarei S; Hosseini ES; Kiani J; Shahbazi A; Nourizadeh H; Eslami M; Dorgalaleh A; Sahlolbei M; Hamblin MR; Karimi M
    Nanotechnology; 2021 Nov; 33(7):. PubMed ID: 34727527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing.
    Rohiwal SS; Dvorakova N; Klima J; Vaskovicova M; Senigl F; Slouf M; Pavlova E; Stepanek P; Babuka D; Benes H; Ellederova Z; Stieger K
    Sci Rep; 2020 Mar; 10(1):4619. PubMed ID: 32165679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing.
    Xiu K; Saunders L; Wen L; Ruan J; Dong R; Song J; Yang D; Zhang J; Xu J; Chen YE; Ma PX
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Citrobacter freundii using CRISPR/Cas9 system.
    Alfaro T; Elmore JR; Stromberg ZR; Hutchison JR; Hess BM
    J Microbiol Methods; 2022 Sep; 200():106533. PubMed ID: 35779647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
    Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
    J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.